IGF-1R IS A PREDICTIVE BIOMARKER FOR EGFR TKI (GEFITINIB) RESISTANCE IN NON-SMALL CELL LUNG CANCER USING IHC AND AQUA TECHNOLOGY

被引：0
|
作者：
Kato, Yasufumi [1 ]
Wynes, Murry W. [1 ]
Mascaux, Celine [1 ]
Asuncion, Bernadette G. Reyna [1 ]
Cindy Tran [1 ]
Yoshida, Koichi [2 ]
Matsubayashi, Jun [3 ]
Ohira, Tatsuo [2 ]
Furukawa, Kinya [4 ]
Nagao, Toshitaka [3 ]
Ikeda, Norihiko [2 ]
Hirsch, Fred R. [5 ]
机构：
[1] Univ Colorado Denver, Div Med Oncol, Denver, CO USA
[2] Tokyo Med Univ, Div Thorac Surg, Tokyo 1608402, Japan
[3] Tokyo Med Univ, Div Anat Pathol, Tokyo 1608402, Japan
[4] Tokyo Med Univ, Div Thorac Surg, Ibaraki Med Ctr, Tokyo 1608402, Japan
[5] Univ Colorado Denver, Div Med Oncol & Pathol, Denver, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
AQUA; immunohistochemistry; IGF-1R; Predictive marker;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S449 / S450
页数：2
相关论文
共 50 条
  • [1] IGF-1R and EGFR expression and IGF-1R mutational status in non-small cell lung cancer (NSCLC)
    Forde, Lydia
    Gately, Kathy
    Gray, Stephen
    Cuffe, Sinead
    Easty, David
    O'Byrne, Ken
    CANCER RESEARCH, 2010, 70
  • [2] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Peled, Nir
    Wynes, Murry W.
    Ikeda, Norihiko
    Ohira, Tatsuo
    Yoshida, Koichi
    Qian, Jin
    Ilouze, Maya
    Brenner, Ronen
    Kato, Yasufumi
    Mascaux, Celine
    Hirsch, Fred R.
    CELLULAR ONCOLOGY, 2013, 36 (04) : 277 - 288
  • [3] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Nir Peled
    Murry W. Wynes
    Norihiko Ikeda
    Tatsuo Ohira
    Koichi Yoshida
    Jin Qian
    Maya Ilouze
    Ronen Brenner
    Yasufumi Kato
    Celine Mascaux
    Fred R. Hirsch
    Cellular Oncology, 2013, 36 : 277 - 288
  • [4] ERK Phosphorylation Is Predictive of Resistance to IGF-1R Inhibition in Small Cell Lung Cancer
    Zinn, Rebekah L.
    Gardner, Eric E.
    Marchionni, Luigi
    Murphy, Sara C.
    Dobromilskaya, Irina
    Hann, Christine L.
    Rudin, Charles M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 1131 - 1139
  • [5] COMBINED INHIBITION OF IGF-1R ENHANCES THE EFFECTS OF GEFITINIB IN A HUMAN NON-SMALL CELL LUNG CANCER RESISTANT CELL LINE
    Qi, H.
    RESPIROLOGY, 2011, 16 : 183 - 183
  • [6] Inhibiting IGF-1R attenuates cell proliferation and VEGF production in IGF-1R over-expressing EGFR mutant non-small cell lung cancer cells
    Yeo, Chang Dong
    Kim, Young Ae
    Lee, Hwa Young
    Kim, Jin Woo
    Lee, Sang Haak
    Kim, Seung Joon
    Kwon, Soon Seog
    Kim, Yong Hyun
    Kim, Seok Chan
    EXPERIMENTAL LUNG RESEARCH, 2017, 43 (01) : 29 - 37
  • [7] TARGETING THE IGF-1R SIGNALLING PATHWAY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Forde, Lydia
    Gray, Steven G.
    Gately, Kathy
    O'Byrne, Kenneth J.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S775 - S776
  • [8] Targeting the IGF-1R signalling pathway in non-small cell lung cancer (NSCLC)
    Forde, L.
    Gately, K.
    Gray, S. G.
    O'Byrne, K. J.
    LUNG CANCER, 2011, 71 : S4 - S4
  • [9] EGFR and K-Ras mutations and resistance of lung cancers to IGF-1R TKI
    Kim, Woo-Young
    Prudkin, Ludmila
    Feng, Lei
    Kim, Edward
    Hennessy, Bryan
    Lee, Ju-Seog
    Lee, J. Jack
    Glisson, Bonnie
    Lippman, Scott
    Wistuba, Ignacio
    Hong, Waun Ki
    Lee, Ho-Young
    CANCER RESEARCH, 2012, 72
  • [10] Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
    Lixia Ju
    Caicun Zhou
    Cancer Cell International, 13
12345